» Articles » PMID: 16641092

Pre-B Cell Proliferation and Lymphoblastic Leukemia/high-grade Lymphoma in E(mu)-miR155 Transgenic Mice

Overview
Specialty Science
Date 2006 Apr 28
PMID 16641092
Citations 511
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) represent a newly discovered class of posttranscriptional regulatory noncoding small RNAs that bind to targeted mRNAs and either block their translation or initiate their degradation. miRNA profiling of hematopoietic lineages in humans and mice showed that some miRNAs are differentially expressed during hematopoietic development, suggesting a role in hematopoietic cell differentiation. In addition, recent studies suggest the involvement of miRNAs in the initiation and progression of cancer. miR155 and BIC, its host gene, have been reported to accumulate in human B cell lymphomas, especially in diffuse large B cell lymphomas, Hodgkin lymphomas, and certain types of Burkitt lymphomas. Here, we show that E(mu)-mmu-miR155 transgenic mice exhibit initially a preleukemic pre-B cell proliferation evident in spleen and bone marrow, followed by frank B cell malignancy. These findings indicate that the role of miR155 is to induce polyclonal expansion, favoring the capture of secondary genetic changes for full transformation.

Citing Articles

Screening the human miRNA interactome reveals coordinated up-regulation in melanoma, adding bidirectional regulation to miRNA networks.

Jame-Chenarboo F, Reyes J, Twells N, Ng H, Macdonald D, Hernando E Sci Adv. 2025; 11(2):eadr0277.

PMID: 39792681 PMC: 11721578. DOI: 10.1126/sciadv.adr0277.


The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma.

Koumpis E, Georgoulis V, Papathanasiou K, Papoudou-Bai A, Kanavaros P, Kolettas E Biomedicines. 2025; 12(12.

PMID: 39767565 PMC: 11673977. DOI: 10.3390/biomedicines12122658.


Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.

Anvari S, Nikbakht M, Vaezi M, Amini-Kafiabad S, Ahmadvand M Cancer Cell Int. 2024; 24(1):410.

PMID: 39702293 PMC: 11660508. DOI: 10.1186/s12935-024-03596-8.


DGNMDA: Dual Heterogeneous Graph Neural Network Encoder for miRNA-Disease Association Prediction.

Lu D, Zhang Q, Zheng C, Li J, Yin Z Bioengineering (Basel). 2024; 11(11).

PMID: 39593792 PMC: 11591469. DOI: 10.3390/bioengineering11111132.


Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.


References
1.
Eis P, Tam W, Sun L, Chadburn A, Li Z, Gomez M . Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005; 102(10):3627-32. PMC: 552785. DOI: 10.1073/pnas.0500613102. View

2.
Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M . The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol. 2006; 8(3):278-84. DOI: 10.1038/ncb1373. View

3.
Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

4.
Chen C, Lodish H . MicroRNAs as regulators of mammalian hematopoiesis. Semin Immunol. 2005; 17(2):155-65. DOI: 10.1016/j.smim.2005.01.001. View

5.
Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen B . Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer. 2005; 45(2):147-53. DOI: 10.1002/gcc.20273. View